Hyloris Pharmaceuticals S.A. carries a market capitalization of 122.64M, placing it among publicly traded companies globally.
| Market Cap | 122.64M |
| Enterprise Value | N/A |
Hyloris Pharmaceuticals S.A.'s stock has declined approximately -30.25478% over the past 52 weeks. The 50-day moving average sits at 4.94, while the 200-day moving average is 5.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | -30.25478% |
| 50-Day Moving Average | 4.94 |
| 200-Day Moving Average | 5.93 |
| Average Volume (20 Days) | N/A |